Clinical Trial Update: Sit Less Program for Patients With Type 2 Diabetes [NA]

View source ↗

Summary

A Vanderbilt University study evaluating a Sit Less program for patients with Type 2 diabetes mellitus was terminated, and results were posted on 2025-03-13.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Vanderbilt University | Conditions: Type 2 Diabetes, Sedentary Behavior | NA | Status: TERMINATED | Results posted: 2025-03-13